Every story in this section, newest first — page 251 of 373.
General Mills (NYSE:GIS) reported a sharp decline in its third-quarter financial results for the period ended February 22, 2026, as the consumer foods giant navigates a complex portfolio restructuring and rising operational costs.
Ovid Therapeutics (NASDAQ:IVID) announced a $60 million private placement to fund the expansion of its clinical pipeline into tuberous sclerosis complex seizures and infantile spasms.
Yuanbao (NASDAQ:YB) reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025, delivering a masterclass in high-growth, high-margin fintech execution.
Weibo (NASDAQ:WB) announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, demonstrating the platform's enduring position as China’s leading social media hub for real-time content.
Five Below (NASDAQ:FIVE) reported stellar financial results for the fourth quarter and fiscal year ended January 31, 2026, showcasing the strength of its high-growth value retail model.
Micron Technology (NASDAQ:MU) reported record-breaking financial results for its fiscal second quarter ended February 26, 2026, as the company continues to capitalize on the unprecedented demand for memory and storage solutions sparked by artificial intelligence.
FedEx (NYSE:FDX) has initiated the final phase of its multi-year operational overhaul, announcing plans to close nine shipping facilities across New York and one in Pennsylvania.
Arvinas (NASDAQ:ARVN) today presented positive data from its Phase 1 clinical trial of ARV-102, an investigational oral PROTAC (PROteolysis TArgeting Chimera) designed to treat neurodegenerative diseases.
Neonode (NASDAQ:NEON) reported its financial results for the fiscal year ended December 31, 2025, characterized by a strategic shift in its technology portfolio and a significant non-recurring capital injection.
SailPoint Technologies (NASDAQ:SAIL) announced financial results for its fourth quarter and full fiscal year ended January 31, 2026, marking a significant milestone as the company surpassed $1 billion in annual revenue.
Nvidia (NASDAQ:NVDA) has begun restarting its manufacturing lines for H200 processors destined for the Chinese market, according to CEO Jensen Huang.
One Stop Systems (NASDAQ:OSS) reported a transformative fourth quarter for the fiscal year ended December 31, 2025, marked by explosive top-line growth and a significant shift in its corporate structure.
Williams-Sonoma (NYSE:WSM) reported financial results for the fourth quarter and fiscal year ended February 1, 2026, revealing a resilient top line tempered by significant macroeconomic headwinds.
TOYO (NASDAQ:TOYO) reported preliminary, unaudited financial results for the fiscal year ended December 31, 2025, highlighting a transformative year of global capacity expansion and robust shipment volumes.
Protagonist Therapeutics (NASDAQ:PTGX) announced today that the U.S. Food and Drug Administration (FDA) has approved ICOTYDE (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 and older weighing at least 40 kg.
The Progressive Corporation (NYSE:PGR) released its monthly financial results for February 2026, demonstrating continued growth in its customer base and sustained underwriting profitability.
Dogwood Therapeutics (NASDAQ:DWTX) reported its fourth-quarter and full-year 2025 financial results, highlighting a pivot toward late-stage clinical development for its lead analgesic candidate, Halneuron®.
Lifeward (NASDAQ:LFWD) reported its fourth-quarter and full-year 2025 financial results on Wednesday, March 18, 2026, highlighting a year of significant structural changes and improved reimbursement access.
Cingulate (NASDAQ:CING) announced its fourth-quarter and full-year 2025 financial results alongside several critical regulatory milestones on March 18, 2026.
InspireMD (NASDAQ:NSPR) reported a significant acceleration in its commercial operations for the fourth quarter of 2025, fueled by the successful U.S. market introduction of its CGuard Prime Carotid Stent System.
Kanzhun (NASDAQ:BZ), the leading online recruitment platform in China, reported a significant leap in profitability for the 2025 fiscal year, driven by steady revenue growth and a dramatic improvement in operating efficiency.
Jabil (NYSE:JBL) today reported preliminary, unaudited financial results for its second quarter of fiscal year 2026, delivering a performance that exceeded internal guidance and Wall Street consensus.
Spire Global (NYSE:SPIR) reported fourth-quarter 2025 financial results characterized by a dramatic reduction in net loss and strong organic growth within its core data and space services segments.
Macy’s (NYSE:M) reported fourth-quarter 2025 financial results that cleared the high end of its previous guidance, driven by robust luxury demand and an accelerating turnaround within its core department store fleet.
